Adotevi O, Vernerey D, Jacoulet P, Meurisse A, et al. Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study. J Clin Oncol 2022 Sep 7:JCO2200096. doi: 10.1200/JCO.22.00096.
PMID: 36070539